Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-17
2005-05-17
Ford, John M. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S225000, C514S365000, C514S374000, C514S378000, C514S406000, C548S146000, C548S356100, C548S215000, C548S240000
Reexamination Certificate
active
06894049
ABSTRACT:
The present invention relates to platinum antitumor drugs. In particular, it relates to platinum complexes having formula Ia or Ibor a pharmaceutically acceptable salt thereofwherein:each A is independently an anion;each B is independently halo, hydroxy, carboxylate, carbamate or a carbonate ester,Z is a substituted 5- or 6-membered, heterocyclic moiety wherein at least one substituent sterically hinders access of the Pt atom to a DNA strand of a tumor cell, and wherein Z is other than pyridine; andX is NH3or mono- or dialkyl substituted NH3.which are active against cancer cells and have improved aqueous solubility and activity.
REFERENCES:
patent: 4329299 (1982-05-01), Hydes
patent: 4533502 (1985-08-01), Rochon et al.
patent: 4760155 (1988-07-01), Heffernan et al.
patent: 4921963 (1990-05-01), Skov et al.
patent: 5194645 (1993-03-01), Barnard
patent: 5244919 (1993-09-01), Abrams et al.
patent: 5547982 (1996-08-01), Abrams et al.
patent: 5624919 (1997-04-01), Farrell
patent: 5665771 (1997-09-01), Murrer
patent: 0287317 (1988-10-01), None
patent: 0727430 (1996-08-01), None
patent: 2137198 (1984-10-01), None
patent: WO 9507698 (1995-03-01), None
patent: WO 0056743 (2000-09-01), None
patent: WO 0061590 (2000-10-01), None
CAS printout for Sok et al. Chem. Abstract 107: 129989 (1987).*
CAS printout for Muir et al. Chem. Abstract 108: 215259 (1988).*
CAS printout for Broomhead et al. Chem. Abstract 124: 248674 (1996).*
CAS printout for Wienkotter et al.*
CAS printout for Rochon et al.*
CAS printout for de Oliverira et al.*
Bierbach, U. et al.(1999)Inorg Chem38(15):3535-3542.
Broomhead, J. et al. (1995)Inorg Chim Acta240(1-2):13-17.
Matthews, J. et al. (1996)Br J Cancer, Suppl., 74(27):s200-s203.
Muir, M. et al. (1988)Inorg Chim Acta151 (3):209-213.
Rochon, F. et al. (1991)Inorg Chem30(24):4531-4535.
Saudek, V. et al. (1985)J Inorg Biochem23(1):55-72.
Skov, K. et al. (1987)Chem-Biol Interact62(2):117-129.
Skov, K. et al. (12987)Radiat Res112(2):273-282.
Skov, K. et al. (1990)Int J Radiat Biol57(5):947-958.
Holford et al., Anti-Cancer Drug Des. (1998) 13:1.
Holford et al., Br. J. Cancer (1998) 77:366.
Kelland et al., Cancer Res. (1992) 52:822.
Kelland et al., Cancer Res. (1992) 52:3857.
Kelland et al., Cancer REs. (1993) 53:2581.
Raynaud et al., Clin. Cancer Res. (1997) 3:2063-2074.
Wong et al., Chem. Rev. (1999) 9:2451-2466.
Abrams et al., Inorg. Chim. Acta (1987) 131:3-4.
Braddock et al., Chem. Biol. Interactions (1975) 11:145-161.
Courtot et al., J. Organometallic Chem. (1978) 145:343-357.
Giandomenico et al., Inorg. Chem. (1995) 34:1015-1021.
Holford et al., Anti-Cancer Drug Des. (1998) 13:1.
Holford et al., Br. J. Cancer (1998) 77:366-373.
Kelland et al., Cancer Res. (1992) 52:822.
Kelland et al., Cancer Res. (1992) 52:3857.
Kelland et al., Cancer Res. (1992) 53:2581.
Kong and Rochon, Canadian J. Chem. (1978) 56:441-445.
Kong, P.-C. et al. (1978), “Reactions of Potassium Tetrachloroplatinate (11) with Pyridine Derivatives in Dimethylformamide and Synthesis of Potassium Trichloro(pyridine)platinum(11),”Chemical Abstracts89(4): abstract No. 35686.
Kong et al., Can. J. Chem. (1979) 57:682-684.
Raynaud et al., Clin. Cancer Res. (1997) 3:2063-2074.
Rochon, F.D. et al. (1988). “Synthesis and Studies of Platinum (II) Compounds of the Types K'Pt(amine)C13! and 'Pt(amine)(acetonitrile)C12!,”Chemical Abstracts108(24): abstract No.215224.
Rochon, F.D. et al., Can J. Chem., 64:1894-1896 (1986).
Rochon, F.D. et al., Can J. Chem., 74:2121-2130 (1996).
Rochon, F.D. et al., Can J. Chem., 58: 97-101 (1980).
Rochon, F.D. et al., Can J. Chem., 33:4485-4493 (1994).
Talman et al., Chemical Abstracts (1997) 126(4):abstract No. 194433.
Wong et al., Chem. Rev. (1999) 9:2451-2466.
Giandomenico Christen M.
Wong Ernest S. Y.
AnorMED Inc.
Ford John M.
Liu Hong
Morrison & Foerster / LLP
LandOfFree
Platinum complexes as antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platinum complexes as antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platinum complexes as antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3385880